Quantification of risk factors for herpes zoster: population based case-control study
Harriet J Forbes, Krishnan Bhaskaran, Sara L Thomas, Tim Clayton, Sinéad M Langan(2014)
Quantification of risk factors for herpes zoster: population based case-control study.
BMJ, doi: http://dx.doi.org/10.1136/bmj.g2911
- Link to fulltext article
- Objectives To quantify the effects of possible risk factors for herpes zoster at different ages.
Design Case-control study.
Setting: UK Clinical Practice Research Datalink primary care data.
Participants: 144 959 adults diagnosed with zoster between 2000 and 2011; 549 336 age, sex, and practice matched controls.
Main outcome measures: Conditional logistic regression was used to generate adjusted odds ratios to estimate the strength of association of each potential risk factor with zoster and assess effect modification by age.
Results: The median age of the cases and controls was 62 years. Factors associated with increased risk of zoster included rheumatoid arthritis (3111 (2.1%) v 8029 (1.5%); adjusted odds ratio 1.46, 99% confidence interval 1.38 to 1.55), inflammatory bowel disease (1851 (1.3%) v 5118 (0.9%); 1.36, 1.26 to 1.46), chronic obstructive pulmonary disease (6815 (4.7%) v 20 201 (3.7%); 1.32, 1.27 to 1.37), asthma (10 243 (7.1%) v 31 865 (5.8%); 1.21, 1.17 to 1.25), chronic kidney disease (8724 (6.0%) v 29 437 (5.4%); 1.14, 1.09 to 1.18), and depression (6830 (4.7%) v 22 052 (4.0%); 1.15, 1.10 to 1.20). Type 1, but not type 2, diabetes showed some association with zoster (adjusted odds ratio 1.27, 1.07 to 1.50). The relative effects of many assessed risk factors were larger in younger patients. Patients with severely immunosuppressive conditions were at greatest risk of zoster—for example, patients with lymphoma (adjusted odds ratio 3.90, 3.21 to 4.74) and myeloma (2.16, 1.84 to 2.53), who are not eligible for zoster vaccination.
Conclusions: A range of conditions were associated with increased risk of zoster. In general, the increased risk was proportionally greater in younger age groups. Current vaccines are contraindicated in people at the greatest risk of zoster, highlighting the need for alternative risk reduction strategies in these groups.
- Author for correspondence
- Harriet Forbes
- Email for correspondence
Clinical code lists:
No code lists have been uploaded for this article yet.
0 comments have been posted.
Please log in to leave a comment.